A new technique called MAP-seq uses RNA bar codes to quickly and cheaply chart connections between brain cells.
New evidence in the battle to control a gene-editing technology that is worth billions.
A novel solution for Parkinson’s patients who find their treatments wearing off.
Scientists have developed a new drug that promises the pain-numbing effects of opioids without the addiction.
A scientist says a blood test that can discern a fetus’s entire genome is coming.
The Apple CEO covered almost everything—but it’s what he didn’t say that’s most interesting.
As they try to gain more influence with regulators and policymakers, several of the top technology companies are increasing the amount of money they spend on lobbying.
The Mexican market offers great opportunity for mobile technologies, but it comes with risk.
Yet more proof that innovation isn’t only for the young.
Inside the long, costly effort to cure diabetes with stem cells.